Raffaele Conca

1.5k total citations
54 papers, 533 citations indexed

About

Raffaele Conca is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Raffaele Conca has authored 54 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 12 papers in Immunology. Recurrent topics in Raffaele Conca's work include Cancer Genomics and Diagnostics (8 papers), Colorectal Cancer Treatments and Studies (8 papers) and Renal cell carcinoma treatment (7 papers). Raffaele Conca is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Colorectal Cancer Treatments and Studies (8 papers) and Renal cell carcinoma treatment (7 papers). Raffaele Conca collaborates with scholars based in Italy, Germany and United Kingdom. Raffaele Conca's co-authors include Roberto Petrioli, Giandomenico Roviello, Corrado Sarzanini, Edoar̈do Mentasti, Ornella Abollino, Maurizio Aceto, Mery Malandrino, Michele Aieta, Antonella Licchetta and Martina Catalano and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Raffaele Conca

52 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raffaele Conca Italy 12 233 116 116 106 72 54 533
Laura Testa Brazil 13 748 3.2× 244 2.1× 190 1.6× 103 1.0× 204 2.8× 59 977
Jennette D. Sison United States 20 227 1.0× 114 1.0× 152 1.3× 428 4.0× 202 2.8× 33 1.0k
Junhua Lin China 13 206 0.9× 69 0.6× 40 0.3× 107 1.0× 78 1.1× 21 509
Fan Luo China 15 227 1.0× 120 1.0× 93 0.8× 312 2.9× 148 2.1× 57 761
Dongbo Yuan China 14 89 0.4× 234 2.0× 43 0.4× 274 2.6× 161 2.2× 37 624
Zhimin Wei China 15 170 0.7× 126 1.1× 50 0.4× 187 1.8× 130 1.8× 68 570
Akira Ishizaki Japan 15 196 0.8× 75 0.6× 43 0.4× 170 1.6× 54 0.8× 35 676
Manuel Díez‐Alonso Spain 16 294 1.3× 213 1.8× 22 0.2× 225 2.1× 71 1.0× 91 918
Alain Monnereau France 16 315 1.4× 82 0.7× 66 0.6× 76 0.7× 97 1.3× 35 814
Trần Nam Thắng Vietnam 12 283 1.2× 265 2.3× 55 0.5× 103 1.0× 61 0.8× 31 536

Countries citing papers authored by Raffaele Conca

Since Specialization
Citations

This map shows the geographic impact of Raffaele Conca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffaele Conca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffaele Conca more than expected).

Fields of papers citing papers by Raffaele Conca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffaele Conca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffaele Conca. The network helps show where Raffaele Conca may publish in the future.

Co-authorship network of co-authors of Raffaele Conca

This figure shows the co-authorship network connecting the top 25 collaborators of Raffaele Conca. A scholar is included among the top collaborators of Raffaele Conca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffaele Conca. Raffaele Conca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Catalano, Martina, Ugo De Giorgi, Davide Bimbatti, et al.. (2024). Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or Pazopanib. Clinical Genitourinary Cancer. 22(2). 514–522.e1. 2 indexed citations
2.
Lanz, Anna-Lisa, Alper Özcan, Murat Cansever, et al.. (2023). A Novel Biallelic LCK Variant Resulting in Profound T-Cell Immune Deficiency and Review of the Literature. Journal of Clinical Immunology. 44(1). 1–1. 5 indexed citations
3.
Catalano, Martina, Ugo De Giorgi, Marco Maruzzo, et al.. (2022). Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma. Biomedicines. 10(10). 2444–2444. 3 indexed citations
4.
Roviello, Giandomenico, Martina Catalano, Ugo De Giorgi, et al.. (2022). Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors. Frontiers in Oncology. 12. 918413–918413. 6 indexed citations
5.
6.
Li, Yue, Thomas Fröhlich, Thomas Magg, et al.. (2022). Valosin-containing protein-regulated endoplasmic reticulum stress causes NOD2-dependent inflammatory responses. Scientific Reports. 12(1). 3906–3906. 2 indexed citations
7.
Passarelli, Anna, Giovanna Galdo, Teresa Pellegrino, et al.. (2021). Therapeutic management of a symptomatic Kaposi’s sarcoma patient with renal failure undergoing haemodialysis: A case report. Dermatology Reports. 14(1). 9113–9113. 1 indexed citations
8.
Catalano, Martina, et al.. (2020). FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Stubbe, Hans, Christine Dahlke, Julia Roider, et al.. (2020). Integration of microarray data and literature mining identifies a sex bias in DPP4+CD4+ T cells in HIV-1 infection. PLoS ONE. 15(9). e0239399–e0239399. 4 indexed citations
10.
Roviello, Giandomenico, Martina Catalano, Alberto D’Angelo, et al.. (2020). Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer. Scientific Reports. 10(1). 19281–19281. 11 indexed citations
11.
Catalano, Martina, Giandomenico Roviello, Raffaele Conca, et al.. (2020). Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study. Current Cancer Drug Targets. 20(11). 887–895. 7 indexed citations
12.
Roviello, Giandomenico, et al.. (2019). The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer. Investigational New Drugs. 37(3). 524–530. 2 indexed citations
13.
Magg, Thomas, Volker Wiebking, Raffaele Conca, et al.. (2018). IPEX due to an exon 7 skipping FOXP3 mutation with autoimmune diabetes mellitus cured by selective TReg cell engraftment. Clinical Immunology. 191. 52–58. 14 indexed citations
14.
15.
Roviello, Giandomenico, Roberto Petrioli, Alberto Bonetta, et al.. (2018). Corticosteroid switch in heavily pre-treated castration-resistant prostate cancer patients progressed on abiraterone acetate plus prednisone. Investigational New Drugs. 36(6). 1110–1115. 8 indexed citations
16.
Tartarone, Alfredo, Pasqualina Giordano, Rosa Lerose, et al.. (2017). Progress and challenges in the treatment of small cell lung cancer. Medical Oncology. 34(6). 110–110. 25 indexed citations
17.
Petrioli, Roberto, Antonella Licchetta, Giandomenico Roviello, et al.. (2012). CEA and CA19.9 as Early Predictors of Progression in Advanced/Metastatic Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy and Bevacizumab. Cancer Investigation. 30(1). 65–71. 27 indexed citations
18.
Petrioli, Roberto, Raffaele Conca, Edoardo Francini, et al.. (2011). Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study. British Journal of Cancer. 104(4). 613–619. 10 indexed citations
19.
Conca, Raffaele, Paola Magistroni, F. Rosati, et al.. (2008). B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome. Transplant Immunology. 19(3-4). 238–243. 5 indexed citations
20.
Conca, Raffaele, et al.. (2005). The Italian Quality Control Scheme for Crossmatching Procedures and HLA Sera Screening: The 2002 Pilot Study. Archives of Pathology & Laboratory Medicine. 129(11). 1470–1475. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Testa Breakdown of academic impact, for papers by Jennette D. Sison Breakdown of academic impact, for papers by Junhua Lin Breakdown of academic impact, for papers by Fan Luo Breakdown of academic impact, for papers by Dongbo Yuan Breakdown of academic impact, for papers by Zhimin Wei Breakdown of academic impact, for papers by Akira Ishizaki Breakdown of academic impact, for papers by Manuel Díez‐Alonso Breakdown of academic impact, for papers by Alain Monnereau Breakdown of academic impact, for papers by Trần Nam Thắng
Rankless by CCL
2026